Company intelligence / Profile preview

Delos Capital

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Delos Capital is a global venture capital firm focused on investing in innovative life sciences companies developing breakthrough therapeutics and medical technologies. Its investments have led to multiple new drug approvals and device clearances by regulatory bodies like the FDA.

Therapeutic areas: OncologyCardiovascularMetabolic DisordersImmunology
Modalities: Small moleculeMonoclonal antibodymRNA-based drugsRadiopharmaceutical
Industry: Investors

Partnerships

Pfizer VenturesJohnson & Johnson Innovation

Beyond the preview

Go deeper on Delos Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Delos Capital.

Explore the full profile